Literature DB >> 31967164

Copper chalcogenide materials as photothermal agents for cancer treatment.

Kun Liu1, Kai Liu2, Junchao Liu1, Qilong Ren3, Zhen Zhao1, Xiaoyu Wu1, Dalin Li4, Fukang Yuan5, Kaichuang Ye1, Bo Li1.   

Abstract

Copper-based chalcogenide nanomaterials have made tremendous progress for cancer theranostics due to their simple preparation, low cost, stable performance, and easy functionalization. But a systematic review and analysis about them does not exist. Therefore, we offer an account, mainly focusing on the design and functionalization of the copper-based chalcogenide nanomaterials for cancer theranostics, aiming to briefly demonstrate the design and concepts, summarize some of the past studies and analyze the development trends in the copper-based chalcogenide nanomaterials for clinical application.

Entities:  

Year:  2020        PMID: 31967164     DOI: 10.1039/c9nr08737k

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  4 in total

1.  Fluorescence imaging-guided cancer photothermal therapy using polydopamine and graphene quantum dot-capped Prussian blue nanocubes.

Authors:  Meng Wang; Baolong Li; Yu Du; Huimin Bu; Yanyan Tang; Qingli Huang
Journal:  RSC Adv       Date:  2021-02-24       Impact factor: 3.361

Review 2.  Exploring near-infrared absorbing nanocarriers to overcome cancer drug resistance.

Authors:  Siwei Chu; Ursula Stochaj
Journal:  Cancer Drug Resist       Date:  2020-07-02

Review 3.  The Coppery Age: Copper (Cu)-Involved Nanotheranostics.

Authors:  Caihong Dong; Wei Feng; Wenwen Xu; Luodan Yu; Huiijng Xiang; Yu Chen; Jianqiao Zhou
Journal:  Adv Sci (Weinh)       Date:  2020-08-16       Impact factor: 16.806

4.  In Vivo Assimilation of CuS, Iron Oxide and Iron Oxide@CuS Nanoparticles in Mice: A 6-Month Follow-Up Study.

Authors:  Alberto Curcio; Aurore Van de Walle; Christine Péchoux; Ali Abou-Hassan; Claire Wilhelm
Journal:  Pharmaceutics       Date:  2022-01-13       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.